These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 16440332

  • 1. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C.
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [Abstract] [Full Text] [Related]

  • 3. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC, Rodrigues B, Torres AC, Enzo A, Melo A.
    J Neurol Sci; 2007 Feb 15; 253(1-2):85-7. PubMed ID: 17229441
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R, Gullo K, Nemeth P, Zhang Y, Griggs L.
    Mov Disord; 2012 Feb 15; 27(2):219-26. PubMed ID: 21887710
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 15; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
    Su CS, Lan MY, Liu JS, Chang CC, Lai SL, Wu HS, Chen SS, Chang YY.
    Acta Neurol Taiwan; 2006 Sep 15; 15(3):170-6. PubMed ID: 16995596
    [Abstract] [Full Text] [Related]

  • 9. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 15; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 10. Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease.
    Thomsen TR, Galpern WR, Asante A, Arenovich T, Fox SH.
    Mov Disord; 2007 Nov 15; 22(15):2268-73. PubMed ID: 17876852
    [Abstract] [Full Text] [Related]

  • 11. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T, Peretz C, Moore O, Weizmann N, Giladi N.
    Mov Disord; 2007 Apr 30; 22(6):880-3. PubMed ID: 17290455
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul 30; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin for treatment of parkinsonian sialorrhea.
    Friedman A, Potulska A.
    Neurol Neurochir Pol; 2001 Jul 30; 35 Suppl 3():23-7. PubMed ID: 12001650
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct 30; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A, Rodrigues B, Nóbrega AC.
    J Am Geriatr Soc; 2009 Jan 30; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG, Hunter C, Moore W.
    Neurology; 2004 Jan 13; 62(1):37-40. PubMed ID: 14718694
    [Abstract] [Full Text] [Related]

  • 20. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R.
    Laryngoscope; 2004 Oct 13; 114(10):1856-60. PubMed ID: 15454785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.